Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b

Oncogene

Volumn 29, Issue 9, 2010, Pages 1316-1328

  Anastasiadou, E ^a   Boccellato, F ^a   Vincenti, S ^a   Rosato, P ^a   Bozzoni, I ^a   Frati, L ^a   Faggioni, A ^a   Presutti, C ^a   Trivedi, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

EBV; LMP1; MicroRNA; Mir 29b; TCL1

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LATENT MEMBRANE PROTEIN 1; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NUCLEIC ACID; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CELL DIFFERENTIATION; CELL LINEAGE; CHROMOSOME 7; DOWN REGULATION; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, B-CELL; MICRORNAS; ONCOGENES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 77949265984     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.439     Document Type: Article

References (59)

1. Alexander WS, Adams JM, Cory S. (1989). Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl. Mol Cell Biol 9: 67-73.
2. Amini RM, Berglund M, Rosenquist R, Von Heideman A, Lagercrantz S, Thunberg U, et al. (2002). A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma. Leuk Lymphoma 43: 2179-2189.
3. Baichwal VR, Sugden B. (1988). Transformation of Balb3T3 cells by BNLF-1 gene of Epstein-Barr virus. Oncogene 2: 461-467.
4. Bartel DP, Chen CZ. (2004). Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5: 396-400.
5. Bell AI, Groves K, Kelly GL, Croom-Carter D, Hui E, Chan AT, et al. (2006). Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 87: 2885-2890.
6. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. (2008). Expression of microRNA-146 suppresses NF-kB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27: 5643-5647.
7. Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R, et al. (2002). Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 99: 6955-6960.
8. Boccellato F, Anastasiadou E, Rosato P, Kempkes B, Frati L, Faggioni A, et al. (2007). EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells. J Virol 81: 2274-2282.
9. Calin GA, Croce CM. (2007). Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest 117: 2059-2066.
10. Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, et al. (2008). The Epstein-Barr virus latent membrane protein 1 (LMP1) induces cellular microRNA-146a, a modulator of lymphocyte signaling pathways. J Virol 82: 1946-1958.
11. Cardinaud B, Moreilhon C, Marcet B, Robbe-Sermesant K, Lebrigand K, Mari B, et al. (2009). miR-34b/miR-34c: a regulator of TCL1 expression in 11q-chronic lymphocytic leukaemia? Leukemia 23: 2174-2177.
12. Chang TC, Yu D, Lee YS, Wentzel DA, Arking D, West KM, et al. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50.
13. Cuomo L, Ramquist T, Trivedi P, Wang F, Klein G, Masucci MG. (1992). Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line. Int J Cancer 51: 949-955.
14. Dirmeier U, Hoffmann R, Kilger E, Schultheiss U, Briseno C, Gires O, et al. (2005). Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24: 1711-1717.
15. Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, Hammerschmidt W. (2003). Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus. Cancer Res 63: 2982-2989.
16. Eliopoulos AG, Young LS. (2001). LMP1 structure and signal transduction. Semin Cancer Biol 11: 435-444.
17. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callagari E, et al. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104: 15805-15810.
18. Floettmann JE, Rowe M. (1997). Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation. Oncogene 15: 1851-1858.
19. Floettmann JE, Ward K, Rickinson AB, Rowe M. (1996). Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223: 29-40.
20. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
21. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, et al. (1991). Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107-1115.
22. Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, et al. (1997). Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 90: 1186-1191.
23. Hoyer KK, French SW, Turner DE, Nguyen MT, Renard M, Malone CS, et al. (2002). Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci USA 99: 14392-14397.
24. Hudson GS, Farrell PJ, Barrell BG. (1985). Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8 J Virol 53: 528-535.
25. Hurst DR, Edmonds MD, Scott GK, BEnz CC, Vaidya KS, Welch DR. (2009). Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 69: 1279-1283.
26. Kawanishi M. (1997). Expression of Epstein-Barr virus latent membrane protein protects Jurkat T cells from apoptosis induced by serum deprivation. Virology 228: 244-250. (Pubitemid 27238791)
27. Kaye KM, Izumi KM, Kieff E. (1993). Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90: 9150-9154.
28. Kiss C, Nishikawa J, Takada K, Trivedi P, Klein G, Szekely L. (2003). T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines. Proc Natl Acad Sci USA 100: 4813-4818.
29. Kuppers R. (2005). Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5: 251-262.
30. Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM. (1992). The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem 267: 24157-24160.
31. Lam N, Sandberg ML, Sugden B. (2004). High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus infected cells. J Virol 78: 1657-1664.
32. Lam N, Sugden B. (2003). LMP1, a viral relative of the TNF receptor family signals principally from intracellular compartments. EMBO J 22: 3027-3038.
33. Land H, Parada LF, Weinberg RA. (1983). Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596-602.
34. Lay JD, Chuang SE, Rowe M, Su IJ. (2003). Epstein-Barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogen-esis of hemophagocytic syndrome. J Biomed Sci 10: 146-155.
35. Maruo S, Yang L, Takada K. (2001). Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J Gen Virol 82: 2373-2383.
36. Motsch N, Pfuhl T, Mrazek J, Barth S, Grasser FA. (2007). Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol 4: 131-137.
37. Mott JL, Kobayashi S, Bronk SF, Gores GJ. (2007). mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140.
38. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 104: 1604-1609.
39. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
40. Ohno S, Migita S, Wiener F, Babonits M, Klein G, Mushinski JF, et al. (1984). Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and Abelson virus. J Exp Med 159: 1762-1777.
41. Pajic A, Staege MS, Dudziak D, Schuhmacher M, Spitkovsky D, Eissner G, et al. (2001). Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells. Int J Cancer 93: 810-816.
42. Pekarsky Y, Koval A, Hallas C, Bichi R, Tresini M, Malstrom S, et al. (2000). Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci USA 97: 3028-3033.
43. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, et al. (2006). Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66: 11590-11593.
44. Raab-Traub N. (2001). Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12: 431-441.
45. Rahadiani N, Takakuwa T, Tresnasari K, Morii E, Aozasa K. (2008). Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem Biophys Res Commun 377: 579-583.
46. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, et al. (1987). Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6: 2743-2751.
47. Said JW, Hoyer KK, French SW, Rosenfelt L, Garcia-Lloret M, Koh PJ, et al. (2001). TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. Lab Invest 81: 555-564.
48. Sandberg ML, Kaykas A, Sugden B. (2000). Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression. J Virol 74: 9755-9761.
49. Schultheiss U, Puschner S, Kremmer E, Mak TW, Engelmann H, Hammerschmidt W, et al. (2001). TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J 20: 5678-5691.
50. Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS. (2007). Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 282: 1479-1486.
51. Shair KH, Bendt KM, Edwards RH, Bedford EC, Nielsen JN, et al. (2007). EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas. PLoS Pathog 3: e166.
52. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. (1998). Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91: 1373-1381.
53. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, et al. (2007). Modulation of miR-155 and miR-125b levels following lipopolysaccharide/ TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082-5089.
54. Tsai CN, Tsai CL, Tse KP, Chang HY, Chang YS. (2002). The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA 99: 10084-10089.
55. Virgilio L, Isobe M, Narducci MG, Carotenuto P, Camerini B, Kurosawa N, et al. (1993). Chromosome walking on the TCL1 locus involved in T-cell neoplasia. Proc Natl Acad Sci USA 90: 9275-9279.
56. Wang D, Liebowitz D, Kieff E. (1985). An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43: 831-840.
57. Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, et al. 1988)). Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol 62: 4173-4184.
58. Wang S, Rowe M, Lundgren E. (1996). Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res 56: 4610-4613.
59. Yin Q, Wang X, McBride J, Fewell C, Flemington EK. (2008). B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol Chem 283: 2654-2662.